Weize Huang
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 14
- Drug Transport and Resistance Mechanisms 7
- CAR-T cell therapy research 4
- Pharmacology 10
- Pharmacogenetics and Drug Metabolism 10
- Co-authors
- Nina Isoherranen (16 shared papers)Lindsay C. Czuba (8 shared papers)Jennifer E. Sager (1 shared paper)Mariko Nakano (1 shared paper)Isabelle Ragueneau‐Majlessi (1 shared paper)Dale Miles (3 shared papers)Jessica M. Snyder (2 shared papers)Cathryn A. Hogarth (2 shared papers)
- Journals
- Drug Metabolism and Disposition (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Clinical and Translational Science (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Weize Huang
28 papers receiving 340 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 89
- Transplantation 17
- Oncology 106
- Biochemistry 22
- Pediatrics, Perinatology and Child Health 60
Countries citing papers authored by Weize Huang
This map shows the geographic impact of Weize Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Huang more than expected).
Fields of papers citing papers by Weize Huang
This network shows the impact of papers produced by Weize Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Huang. The network helps show where Weize Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 34 | |
| 2 | 2017 | 30 | |
| 3 | 2019 | 28 | |
| 4 | 2013 | 28 | |
| 5 | 2020 | 27 | |
| 6 | 2020 | 23 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 16 | |
| 9 | 2020 | 15 | |
| 10 | 2019 | 15 | |
| 11 | 2016 | 15 | |
| 12 | 2020 | 14 | |
| 13 | 2001 | 14 | |
| 14 | 2024 | 11 | |
| 15 | 2021 | 9 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 4 |
About Weize Huang
Weize Huang is a scholar working on Oncology, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health and Hematology, having authored 29 papers that have together received 341 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Pharmacological Effects and Toxicity Studies (6 papers), Retinoids in leukemia and cellular processes (5 papers), CAR-T cell therapy research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pharmaceutical studies and practices (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Pharmacology (89 citations), Transplantation (17 citations), Oncology (106 citations), Biochemistry (22 citations) and Pediatrics, Perinatology and Child Health (60 citations). Weize Huang has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Nina Isoherranen, Lindsay C. Czuba, Jennifer E. Sager, Mariko Nakano, Isabelle Ragueneau‐Majlessi, Dale Miles, Jessica M. Snyder, Cathryn A. Hogarth, Peter Stefanov Kourtev and Traci Topping. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics, Clinical and Translational Science and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.